Shore Capital appointed as Joint Broker to Greencore
To thrive after Brexit, we must turbo-charge forgotten corners of the country
Shore Capital acts as Financial Adviser, Nominated Adviser and Joint Broker on Amryt Pharma’s acquisition of Aegerion Pharmaceuticals, Inc.
SEE ALL NEWS
Message from the Executive Chairman
Within our sector coverage Shore Capital follows industries and stocks from top to bottom. In this respect, we are distinctive in offering competitive and well established analysis in FTSE-100 stocks right down to AIM and FTSE Small-Cap equities.